TLR9 and systemic sclerosis: TLR9 recognition of mtDNA DAMPs leading to pro-fibrotic signaling through upregulation, activation, and release of TGF-β has been previously described in other fibrotic disorders such as systemic sclerosis and in a model of prostate cancer [34, 35].